Skip to main content
Download PDF
  • Study protocol
  • Open access
  • Published:

The smoke-free home study: study protocol for a cluster randomized controlled trial of a smoke-free home intervention in permanent supportive housing

BMC Public Health volume 22, Article number: 2076 (2022) Cite this article

Abstract

Background

Formerly chronically homeless adults who live in permanent supportive housing (PSH) have high prevalence of smoking. It is uncommon to find smoke-free policies in PSH because of the concern that such policies contradict PSH’s harm reduction framework and could increase homelessness should residents lose their housing because of the policy. However, in the absence of such policies, non-smoking PSH residents face the harmful effects of secondhand smoke exposure while residents who smoke see increased risks from high rates of smoking throughout their residence. Our pilot work highlighted the feasibility and acceptability of an intervention designed to promote voluntary adoption of a smoke-free home. Here we report a protocol for a cluster randomized controlled trial of the smoke-free home intervention for formerly chronically homeless residents in PSH.

Methods

The smoke-free home intervention provides face-to-face counseling and instruction to PSH residents on how to adopt a smoke-free home and offers training for PSH staff on how to refer residents to tobacco cessation services. We will randomize 20 PSH sites in the San Francisco Bay Area to either the intervention or wait-list control arms. We will enroll 400 PSH residents who smoke cigarettes in their housing unit and 120 PSH staff who work at the sites. At baseline, three- and six-months follow-up, we will ask residents to report their tobacco use and cessation behaviors and adoption of smoke-free homes. We will ask staff to answer questions on their knowledge, attitudes, practices, and barriers related to supporting residents’ smoking cessation. The primary outcome for PSH residents is adoption of smoke-free homes for 90 days or more at six-months follow-up, and the secondary outcome is point prevalence tobacco abstinence. The primary outcome for PSH staff is change in Smoking Knowledge Attitudes Practices survey score.

Discussion

Voluntary adoption of smoke-free homes is a promising approach for reducing exposure to secondhand smoke and reducing tobacco use among a population facing high rates of tobacco-related disease, and is aligned with PSH’s harm reduction framework. Findings from this study have the potential to inform adoption of tobacco control policies among vulnerable populations most at risk for smoking-related harms.

Trial registration

This study was registered with the U.S. National Institute of Health Clinical Trials register on April 22, 2021: NCT04855357.

Background

Tobacco use is more prevalent among low-income and socially marginalized communities than their affluent counterparts, contributing to an unequal burden of tobacco-related diseases, a key health equity issue [1]. Previously chronically homeless individuals residing in permanent supportive housing (PSH) have borne the brunt of structural inequities leading to high rates of tobacco use [1, 2]. PSH is subsidized housing with closely linked or on-site voluntary medical and/or social services for individuals with a history of chronic homelessness and co-occurring mental health conditions, substance use disorders, and disabilities [3, 4]. Chronic homelessness is defined by the U.S. federal government as being continuously homeless for more than 1 year, or having four or more episodes of homelessness over 3 years, which combine to more than 1 year, in addition to having a disabling condition. Approximately 25% of people experiencing current homelessness in the U.S. meet these criteria for chronic homelessness [4]. PSH is an evidence-based approach to ending homelessness and represents the largest type of residential program in the U.S. for individuals who were previously homeless, with over 376,000 beds throughout the country [5]. Housing first is the most common and preferred approach to PSH. Rooted in harm reduction, housing first approaches have no preconditions of abstinence from alcohol or substances and do not require residents to engage in supportive services prior to obtaining or maintaining housing [3].

Negative social determinants of health are associated with high rates of tobacco use among people who experience homelessness [1]. These determinants include extreme poverty and the social marginalization that results from being homeless, increased availability of tobacco products in low-income communities, and limited access to cessation resources and smoke-free housing [1, 6]. Approximately 50% of those living in PSH report current smoking [7]. Mortality rates among PSH residents are at least double that of age-matched individuals in the general population [8] and tobacco-caused chronic diseases including cancers and cardiovascular disease contribute to over 60% of the all-cause mortality of PSH dwelling individuals [8]. Housing inequities disproportionately expose disadvantaged communities to secondhand smoke (SHS) and other cancer risks and contribute to poor access to preventive health care such as cancer screenings [9].

Tobacco use also increases financial strain on this already at-risk population. PSH residents in the San Francisco Bay Area who smoked spent 12% (median, range 5–26%) of their monthly income on tobacco [10]. PSH residents who have an income are required to pay up to 30% of their earnings on their monthly rent, and tobacco spending may interfere with residents’ ability to pay rent [11]. Tobacco expenditures may also interfere with residents’ ability to purchase food and increase risk for food insecurity [12]. Despite high rates of tobacco use and its detrimental impact on PSH residents’ health and financial well-being [12], PSH typically do not have mandated smoke-free policies restricting indoor smoking in living areas nor do they offer cessation services [11, 13].

Tobacco control initiatives

Smoke-free policies and smoking cessation services are among the most effective tobacco control interventions. The Department of Housing and Urban Development (HUD) mandated a smoke-free policy that restricted indoor smoking in public housing authority housing, effective July 2018, and in some housing authority sites, that mandate is accompanied with access to cessation resources [14, 15]. In contrast, smoke-free policies are uncommon in PSH. There is a concern that mandated smoke-free policies may conflict with PSH’s harm-reduction framework, potentially increasing risk of evictions [11]. PSH staff may lack resources and time to enforce a smoke-free policy even if they put one into effect [11], and policies without cessation resources are thought to be minimally effective in promoting smoke-free living environments.

Given this hesitation, encouraging residents to voluntarily designate their homes as smoke-free represents one approach to introducing smoke-free living environments in the absence of a mandated policy. This strategy relies on education and voluntary behavioral change and therefore is aligned with PSH’s harm reduction framework. Smoke-free homes not only reduce exposure to SHS among non-smokers, but they also reduce smoking among smokers. In prior population-based studies, a smoke-free home was associated with reduced consumption, increased quit attempts [16, 17], reduced relapse to smoking, and increased effectiveness of smoking cessation aids [18]. Despite the fact that low-income households were less likely to have smoke-free homes, low-income smokers who had a smoke-free home had similar quit rates to higher-income smokers, suggesting that smoke-free homes could mitigate part of the income disparity in smoking cessation.

We previously conducted a pilot study to evaluate the efficacy of a multi-faceted intervention to increase voluntary adoption of smoke-free homes, i.e., a voluntary no-smoking rule in one’s home, with 100 formerly homeless adults in 15 PSH sites in the San Francisco Bay Area [19]. The intervention consisted of providing a step-by-step guide to residents on how to voluntarily adopt a smoke-free home and training PSH staff on how to refer residents to local cessation resources. At 6 months, 31% of residents adopted a voluntary smoke-free home compared to 12% at baseline.

Study objectives

Here we describe a protocol for a cluster-randomized wait-list controlled trial to evaluate the efficacy of the same smoke-free home intervention on the primary outcome of voluntary adoption of a smoke-free home. This approach of encouraging the voluntary adoption of smoke-free homes offers a novel pathway to increase access to smoke-free living in housing where there is no mandated policy [20].

Methods/design

Study design

We will conduct a cluster-randomized, wait-list controlled trial [21, 22], where eligible PSH sites will be randomized into intervention and wait-list control groups. Those in the wait-list control group will receive usual care first and then cross over to the intervention arm after 6 months (Fig. 1).

Fig. 1
figure 1

Randomization, recruitment, intervention delivery, and assessment schedule. Legend: X indicates measure or action for intervention group, Y indicates measure or action for wait-list control group

Full size image

Intervention

The intervention, based on a train-the-trainer model, will include two parts: 1) study staff will deliver a one-hour counseling intervention to residents on how to adopt a smoke-free home, and 2) study staff will provide training to PSH staff on how to provide brief cessation counseling to residents and refer to local tobacco cessation services. The PI will train study staff and will assess fidelity by conducting observations of the counseling and training sessions and providing feedback to staff.

Theoretical foundation

The individual intervention components are rooted in the social cognitive theory [23], which posits that behavior change takes place as a result of a dynamic and reciprocal interaction of the individual, behavior, and environment. We anticipated that by providing PSH residents knowledge and skills to adopt a smoke-free home, we would increase PSH residents’ engagement with the intervention. To scale up the intervention to multiple PSH sites and to lend rigor and structure to intervention development, we mapped intervention functions to the Behavior Change Wheel (BCW), a theoretical framework that describes barriers to and enablers of the behavior and offers nine possible intervention functions and seven possible policy options to affect behavior change [24,25,26]. The BCW domains and corresponding elements of the intervention are provided in Table 1. The BCW includes three layers [1]: the first uses the Capability, Opportunity, Motivation, Behavior (COM-B) [24, 25] model to highlight key barriers and potential enablers to voluntarily adopting a smoke-free home [2]; the second highlights five intervention options that cuts across individual, social, and organizational influences to address the barriers identified in the COM-B domains; and [3] the third offers three policy and programmatic options to disseminate the intervention [26]. Psychological capability reflects knowledge and awareness, and physical capability refers to skills necessary for behavior change. Opportunity comprises social and physical factors that make behavior change possible. Motivation includes the processes that direct behavior change, including emotional response, habitual processes, and cognitive processes.

Table 1 Mapping the smoke-free home intervention delivery to the Behavior Change Wheel
Full size table

Through our formative work and pilot study [11, 19], we identified that residents’ psychological and physical capability to adopt a smoke-free home was limited by lack of knowledge on the harms of SHS, and lack of skills on how to adopt a smoke-free home. PSH staff also reported a lack of knowledge needed to help residents implement smoke-free homes or access cessation resources. Opportunity was limited by lack of a safe designated smoking zone to smoke outdoors and on-site resources for smoking cessation. Awareness that SHS negatively impacted children and pets was a motivation for smoke-free home adoption; however, indoor co-use of substances decreased motivation to quit. Guided by the BCW framework, the resident intervention will include the following key components: education and skill building for PSH residents using a step-by-step guide on how to adopt a smoke-free home, training for PSH staff on how to provide brief cessation counseling, restrictions that include voluntary adoption of smoke-free homes, persuasion using imagery to encourage smoke-free home adoption, and enablement that includes provision of brief cessation counseling and referrals to cessation services. Study staff will also assist participants in calculating their personal financial costs related to tobacco use and encourage them to use the smoke-free home pledge to designate their home smoke-free. The intervention will be delivered using a culturally-tailored informational pamphlet.

The training for PSH staff includes webinar-style health education on tobacco use and cessation, nicotine addiction, and treatment of nicotine addiction using the 5As for smoking cessation or Ask, Advise or Refer model. Because PSH staff often play an essential role in linking residents to medical and mental health care, the training intervention emphasizes the importance of staff and empowers them to ask, advise, and refer [27] to smoking cessation services. The total time for the PSH staff training is 2 h.

Randomization

We will randomize 20 PSH sites in the San Francisco Bay Area into the intervention and waitlist control arms using restricted randomization, a process which ensures an acceptable level of balance across groups at baseline [22]. We will match intervention and control groups by size of property, geographic location, and current smoking-related policies.

Participants and setting

We aim to enroll 400 PSH residents, with 200 each in the intervention and control arms, with approximately 20 residents per site. Eligible PSH residents are those who are current smokers (smoked at least 100 cigarettes in their lifetime, and smoked daily or non-daily and at least five cigarettes per day in the past 7 days, verified by expired carbon monoxide [CO], ≥ 8 ppm [ppm]) [28], who smoke in their homes, expect to live in the PSH site for an at least 12 months, are 18 years or older, are English proficient and can provide informed consent.

We will also enroll PSH staff (n = 120) for a staff training intervention on how to provide brief cessation counseling. Staff are case managers, property management and administrative staff, nurses, or social workers who have a caseload of residents and ensure the day-to-day functioning of the site and coordinate services for residents. Eligible PSH staff are 18 years and older, are willing to participate in the two-hour training, and are able to provide informed consent.

The PSH settings included are clustered sites where housing and supportive services are delivered to all residents in a single, multi-unit building. These clustered sites can be small (< 30 housing units), medium (30–70 housing units), or large (70–130 housing units), and depending on the agency’s property portfolio, can include between one and 10 staff providing services at each site.

Recruitment and enrollment

Study staff will recruit residents in person by posting flyers at study sites to provide information about the study and publicize the study through a “kick-off” community engagement event targeted to residents at the site. During the kick-off event organized at the PSH site community space, study staff will gather contact information from interested PSH residents and plan to enroll participants after eligibility assessment [29]. Study staff will use the teach-to-goal method to obtain informed consent from the participants [30].

Control

PSH residents and staff in the wait-list control group will receive usual care, which in most PSH sites involves no interventions for smoke-free home adoption or referrals to smoking cessation resources.

Study timeline and follow-up

The study duration for intervention group participants is 6 months. Wait-list control group participants will be offered the intervention after the intervention group participants within the same cluster receive their intervention and have the potential to stay enrolled for up to 1 year. Staff will collect data at baseline, 3 months, and 6 months post-intervention. The process is summarized in Fig. 1.

Reimbursements

We will reimburse all resident participants with $20 gift cards for completing the baseline questionnaire, $15 for the three-month questionnaire, and $25 for the six-month questionnaire. We will pay participants $5 for monthly tracking visits between follow-ups and will pay those selected for random air nicotine monitoring at 6 months an additional $5 for keeping monitors in their home for 7 days. These amounts have been used in prior studies [19, 31,32,33]. We will reimburse PSH staff participants with $20 gift cards upon completion of the baseline questionnaire, $15 for the three-month, and $25 for the six-month questionnaire. We will offer snowball sampling to promote additional recruitment and offer enrolled participants an incentive of $10 for referring any eligible participants to this study, for up to three participants during the study duration.

Retention

For each scheduled visit (i.e., three- and six-months follow-up), we will contact participants at least three times before they are marked as having a missed visit. We will offer monthly incentivized check-in visits (i.e. at two, four, and 5 months) between scheduled assessments that are in person or by telephone to facilitate retention for study follow-up visits. We will contact participants weekly for up to a month before being marked as having a missed visit.

Data collection

We will build questionnaires on Research Electronic Data Capture (REDCap), a secure online data collection platform [34, 35]. Study staff will administer the questionnaires to resident participants, and staff participants will be asked to complete the questionnaires with assistance from study staff.

Measures

PSH residents

Sociodemographic, residential history, and health status

At baseline, we will obtain information on age, sex (sex assigned at birth, current gender), race/ethnicity, education, monthly income (i.e., income from all sources), and health status [36]. For residential history, we will ask participants to provide the length of time they have lived in their current PSH, where they lived prior to current residence, and the number and length of episodes of homelessness in their lifetime [4].

Nicotine dependence and tobacco cessation history

At all three collection periods, we will assess Fagerstrom’s test for nicotine dependence [37]. We will collect cessation history including intention to quit, quit attempt (ever and in the past year), length of the last quit attempt, and use of cessation aids during the last quit attempt (e.g., medications, telephone quit line), and whether they have had encounters with housing staff around smoking cessation services.

Alternative tobacco and nicotine product use

At baseline we will obtain information on ever use, and at follow-ups we will obtain information on use in the past 30 days and number of days used of non-cigarette tobacco and nicotine products including electronic cigarettes, cigars, little cigars, smokeless tobacco, hookah/waterpipe, and blunts.

Chronic diseases

At baseline, we will ask participants whether they have received a diagnosis of liver, renal, or cardiovascular disease, hypertension, stroke, diabetes, cancer, arthritis, asthma, or chronic obstructive pulmonary disease [38].

Mental health

At baseline and follow-up, we will assess depression using the Center for Epidemiologic Studies Depression Scale [39], anxiety using a seven-item anxiety scale (Generalized Anxiety Disorder-7, GAD-7) [40], post-traumatic stress disorder using the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) [41], and urban stress using the Urban Life Stressors Scale [42]. We will also ask about history of diagnosis of schizophrenia or bipolar disorder.

Alcohol and substance use disorders

At all three collection periods, we will administer the Alcohol, Smoking and Substance Involvement Screening Test version 3.0 (WHO-ASSIST) [43,44,45]. In order to assess volume of alcohol consumed, we will administer the consumption questions from the Alcohol Use Disorders Identification Test (AUDIT-C) [46, 47]. To assess cannabis use, we will also administer the Cannabis Use Disorders Identification Test-Revised (CUDIT-R) [48].

Maltreatment, and subsistence needs

We will ask participants to report whether they had experienced difficulty meeting subsistence needs such as food, utilities, medications, healthcare, phone, clothing, childcare, or anything else in the past 12 months. Because racism and discrimination are central to experiences of homelessness and also related to tobacco use, we will ask participants to report these experiences using the Everyday Discrimination Scale (range 1[almost every day] to 6 [never]) [49].

Attitudes toward tobacco and cannabis smoke-free policy

At baseline and follow-up, we will ask participants to report whether they had experienced secondhand smoke exposure from tobacco and cannabis in the past month inside their apartment, in indoor shared areas like hallways or entryways, in outdoor areas like porches, patios or balconies, and other outdoor areas like the parking lot (never, hardly ever, a few times a month, a few times a week, or every day). We will ask them to report their level of agreement to a hypothetical smoke-free policy inclusive of tobacco and cannabis, including whether they would support such a policy, would try to cut down, would try to stop smoking, would continue to smoke in their apartment, or would try to move to another apartment because of the policy.

Voluntary smoke-free home adoption and smoke-free home rules

We will ask participants to report any rules around smoking in their home (there are no rules around smoking in my home, smoking is allowed anywhere, smoking is allowed some time or some places, smoking is not allowed anywhere in my home). We will ask participants to report whether they have attempted to establish a smoke-free home rule in the past 3 months, whether they have attempted to not smoke in their home in the past 3 months, and the number of days they were smoke-free in the past 3 months. These items will be used to define our primary outcome of self-reported voluntary smoke-free home adoption for 90 days or more at 6 months follow-up. We will ask participants to report their level of agreement to barriers to adopting a smoke-free home.

Satisfaction with intervention

At the follow-up, we will ask intervention participants to rate their satisfaction, usefulness, and quality of the materials using a Likert scale. In addition, we will ask about participants’ exposure to and use of smoking cessation materials provided by PSH staff.

PSH staff

Sociodemographic status

At baseline, we will ask staff to provide their age, sex assigned at birth and gender, race/ethnicity, role in the facility, and smoking history (if applicable).

Smoke-free policies

At all three data collection periods, we will ask staff about smoke-free policies, such as restrictions on indoor e-cigarette or smoked cannabis use, provision of smoking cessation resources, and enforcement of any smoke-free policies. We will ask about any experiences with challenges to policy enforcement or complaints about policies.

Smoking knowledge and attitudes

We will ask PSH staff to provide input on usefulness and satisfaction with the intervention and whether they have referred residents to smoking cessation programs. We will ask PSH staff to complete the Smoking Knowledge Attitudes Practices (SKAP) survey at baseline, 3 months, and 6 months post-intervention (score range 1–5, with a higher score indicating increased knowledge, beliefs, efficacy, and practices, and reduced barriers toward providing smoking cessation care) [19, 50, 51].

Outcomes

PSH residents

The primary outcome is self-reported voluntary adoption of smoke-free homes for 90 days or more at six-months follow-up. We will place passive air nicotine monitoring [52, 53] devices in a random sample of intervention and wait-list control homes for a seven-day period at 6 months follow-up to verify self-reports of smoke-free home adoption. These monitors will be purchased from and analyzed via gas chromatography by the University of California, San Francisco (UCSF) Tobacco Biomarkers Core Laboratory. Study staff will obtain permission at the time of informed consent to place monitors in residents’ rooms for 7 days [52], within 1 week of six-month interview completion. Monitors will be placed at least 1 ft away from windows, corners of the room, and exits [52]. We will rely on the threshold of 0.9743 μg/m3 (sensitivity 69.5% and specific of 81.2%) for a home not being smoke-free [52]. Upon collection, samples will be stored in the UCSF Tobacco Biomarkers Core Laboratory prior to analysis. The secondary outcome is carbon monoxide-verified point prevalence tobacco abstinence at 6 months follow-up (expired carbon monoxide ≤5 ppm is defined as abstinence).

PSH staff

The primary outcome of interest for PSH staff is change in SKAP score from baseline to 6 months follow-up.

Power analyses

This study is powered to detect medium-large effect sizes in the primary and secondary outcomes of interest for PSH residents (self-reported smoke-free home adoption and point prevalence of tobacco abstinence). This anticipated effect is consistent with estimates from the pilot study [19] and previous assessments of smoke-free home interventions which found over 40% change in the intervention group compared to a 25% change in the control group [52]. Power analyses assumed 80% power; two-tailed alpha of 0.05; N = 400 smoking residents recruited from 20 PSH units; 80% retention at 6 months; average six-month site cluster size of 16 residents; group comparisons of six-month binary outcomes describing adoption of a smoke-free home for ≥90 days and point prevalence abstinence from preliminary data, expected six-month control group outcome rates of 12 and 4% for smoke-free home adoption and point prevalence abstinence, respectively; from preliminary data, intra-site outcome correlations of 0.077 (ρSFH) and zero (ρPPA); and mixed logistic models including random intercepts for sites. Estimated design effects equaled 1 + (16–1)ρSFH = 2.16 and 1 + (16–1)ρPPA = 1.0, respectively.

For the primary outcome of voluntary smoke-free home adoption, the minimum detectable effect for the intervention group is 30.3% compared to 12% for the control group, which compares favorably with 31.3% obtained in our pilot study as well [19]. For the secondary outcome of point prevalence abstinence at 6 months, the minimum detectable effect in the intervention group is 12.6% compared to 4% in the control group, which compares favorably with 16.9% obtained in the pilot study [19].

Statistical analysis

First, we will conduct descriptive analyses including means, proportions, variation, and confidence intervals of PSH resident socio-demographic variables including age, gender, and race/ethnicity. Randomization adequacy will be evaluated by considering whether baseline characteristics are independent of intervention group assignment, and attrition analysis will also be conducted. Missing data will be accommodated by multiple imputation [54,55,56]. If any key demographic or risk factors are imbalanced at baseline, propensity score-based adjustment will be included [57,58,59]. Then, we will analyze patterns of smoking cessation behaviors over time to determine the relationship between these practices and voluntary adoption of a smoke-free home. We will conduct primary analysis using intention-to-treat comparisons.

To account for the structure of these data where participants are measured repeatedly over time and are grouped by housing site, we will employ a mixed logistic model with random intercepts for sites and residents. The primary outcome is a binary indicator of smoke-free home adoption which, in an intention-to-treat analysis, will be regressed onto indicators of experimental groups, categorical time (baseline, 3 months, 6 months), and the group-by-time interaction. We will interpret and describe any significant intervention group main effect at follow-up and group-by-time interaction effect.

A secondary analysis will fit a mixed logistic model of the secondary outcome, point prevalence abstinence. Additional analyses will explore mediators (e.g., skills related to smoke-free home adoption, use of referrals to counseling) and moderators (e.g., children or pets at home, indoor cannabis use or other combustible tobacco and nicotine product use) of intervention effects on smoke-free home and point prevalence abstinence outcomes via mixed effects regression models. Replicability of within-group changes on primary and secondary outcomes will be tested by comparing baseline to six-month changes in the intervention group to corresponding six- to 12-month changes in the waitlist group.

Analyses of PSH staff data will include a pre-post training analysis of the smoking knowledge, attitudes, practices, efficacy, and barriers scale using mixed linear models. We will use mixed linear regression models to examine factors associated with change in each of the scales, clustering by site and staff participant ID, and adjusting for demographics, staff smoking status, encounters with residents on providing referrals for cessation, and staff role in the PSH site (e.g., case manager). In addition, we will examine unadjusted SKAP scores by PSH staff attendance of training, smoking status, PSH site and geographic location.

Current status

At the time of the manuscript submission, the trial is actively enrolling participants. Recruitment began in February 2022, and we have rolled out the intervention in three blocks of six sites (i.e., 18 sites). Within each block, there are three intervention and three control sites. We have enrolled 129 participants to date and have completed 3 months follow-up data collection on 79 participants, and 6 months follow-up data collection on 20 participants. We plan to continue recruitment until we reach our target sample size, which we expect to reach by October 2023.

Discussion

This protocol describes a voluntary approach to introducing smoke-free living environments in housing where there is no mandated policy or where a mandated policy may be difficult to enforce. A voluntary approach has the benefit of being self-enforced and has the potential to catalyze a normative shift in smoking behaviors. Early adopters of smoke-free homes could motivate a critical mass of residents in a building to voluntarily adopt a smoke-free home, potentially paving the pathway for a building to become smoke-free. The proposed study protocol offers a potentially useful and scalable approach for other types of multi-unit housing that are considering implementing smoke-free policies.

Federal legislation prohibiting smoking in public housing authority housing does not address other multi-unit living arrangements like housing choice voucher programs or PSH, leaving a gap in the implementation of policies in housing for people that are disproportionately impacted by tobacco use [60]. Intersectional populations including low-income, multi-generational families with elderly residents and children who belong to racial/ethnic minority groups are over-represented in subsidized housing and are vulnerable to the harmful effects of SHS and heightened morbidity and mortality from tobacco use [61,62,63]. Low-income multi-unit housing residents have a higher prevalence of tobacco use than the general population, due in part to tobacco industry targeting of these populations and increased tobacco retail density in low-income communities [64]. These structural and commercial determinants of tobacco use highlight an urgent need for comprehensive smoke-free policies in all forms of multi-unit housing [64].

Current implementation efforts of smoke-free policies in public housing authority housing present important lessons for enforcement. A pre- and post-study that evaluated the effects of the 2018 federal ban on smoking in public housing on air nicotine concentration levels in New York City public housing, found no significant difference in nicotine levels between living areas where the policy was in effect to areas where there was no policy [65]. In a mixed methods evaluation of the federal smoke-free public housing policy in New York City, residents saw limited enforcement of the ban in the year following its implementation [66]. Moreover, qualitative findings suggested that there would be resident and staff resistance to a mandated smoke-free policy [66].

In the context of these challenges, smoke-free home initiatives that include resident endorsement and provision of a designated smoking zone provide a promising alternative because they offer a self-enforced approach to having an indoor smoke-free policy [67]. A voluntary, self-enforced approach could facilitate transition to a building-wide smoke-free policy or increase impact of a smoke-free policy that is in place. Further, smoke-free home interventions that are tied to proven smoking cessation services (such as behavioral counseling and pharmacotherapy) are poised to promote a supportive environment where people are able to quit smoking [20]. Results from our pilot study showed that 17% of participants reported carbon-monoxide verified abstinence at 6 month follow-up, and self-reporting a smoke-free home was associated with abstinence [19].

Housing is an important social determinant of health. People who have experienced homelessness have also faced lifelong trauma and chronic housing instability. Access to affordable housing including supportive housing and services is the foundation for health [68]. When those managing affordable housing demonstrate commitment to reducing environmental exposures like tobacco and the accompanying risk of tobacco-related morbidity and mortality, there is a greater opportunity for recovery. By promoting smoke-free homes and access to cessation services, we capitalize on the opportunity for housing to be the foundation of health and recovery.

Availability of data and materials

No data were analyzed as a part of this protocol paper. Dr. Vijayaraghavan will have full access to all the data collected during the cluster randomized controlled trial and will take responsibility for the integrity of the data and the accuracy of the data analysis. Data will be made available only upon request and in accordance with an established data sharing agreement.

Abbreviations

PSH:

Permanent supportive housing

SFH:

Smoke-free home

SHS:

Second-hand smoke

References

  1. U.S. National Cancer Institute. A Socioecological Approach to Addressing Tobacco-Related Health Disparities. National Cancer Institute Tobacco Control Monograph 22. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2017.

    Google Scholar 

  2. Department of Housing and Urban Development. The 2017 Annual Homeless Assessment Report to Congress 2016. Available at: https://files.hudexchange.info/resources/documents/2017-AHAR-Part-2.pdf.

    Google Scholar 

  3. Tsemberis S, Gulcur L, Nakae M. Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004;94(4):651–6.

    Article  PubMed  PubMed Central  Google Scholar 

  4. The McKinney-Vento Homeless Assistance Act of 2009, U.S. Code Title 42 chapter 119 § 11301 et seq. Available from https://uscode.house.gov/view.xhtml?path=/prelim@title42/chapter119&edition=prelim.

  5. U.S. Department of Housing and Urban Development. The 2021 Annual Homeless Assessment Report (AHAR) to Congress. 2022.

    Google Scholar 

  6. Baggett TP, Tobey ML, Rigotti NA. Tobacco use among homeless people–addressing the neglected addiction. N Engl J Med. 2013;369(3):201–4.

    Article  CAS  PubMed  Google Scholar 

  7. Petersen AB, Stewart HC, Walters J, Vijayaraghavan M. Smoking policy change within permanent supportive housing. J Community Health. 2018;43(2):312–20.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Henwood BF, Byrne T, Scriber B. Examining mortality among formerly homeless adults enrolled in housing first: an observational study. BMC Public Health. 2015;15:1209.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31–46.

    Article  PubMed  Google Scholar 

  10. Petersen AB, Elser H, Nguyen T, Alizaga NM, Vijayaraghavan M. Smoke-free or not: attitudes toward indoor smoke-free policies among permanent supportive housing residents. Am J Health Promot. 2020;34(1):32–41.

    Article  PubMed  Google Scholar 

  11. Alizaga NM, Nguyen T, Petersen AB, Elser H, Vijayaraghavan M. Developing tobacco control interventions in permanent supportive housing for formerly homeless adults. Health Promot Pract. 2020;21(6):972–82.

    Article  PubMed  Google Scholar 

  12. Petersen AB, Elser H, Nguyen T, Alizaga N, Vijayaraghavan M. Smoke-free or not: attitudes toward indoor smoke-free policies among supportive housing residents. Presented at the American public health association annual Metting, 2018 Available at: https://apha.confex.com/apha/2018/meetingappcgi/Paper/413104.

    Google Scholar 

  13. International Agency for Research on Cancer, World Health Organization. Evaluating the Effectiveness of Smoke-free Policies: WHO; 2009. Available at: https://www.iarc.who.int/wp-content/uploads/2018/07/handbook13-0.pdf

    Google Scholar 

  14. U.S. Department of Housing and Urban Development. Instituting Smoke-Free Public Housing, Rule number: 81 FR 87430. 2016 Available at: https://www.federalregister.gov/documents/2016/12/05/2016-28986/instituting-smoke-free-public-housing.

    Google Scholar 

  15. U.S. Department of Housing and Urban Development, Office of Public and Indian Housing. Implementing HUD’s smoke-free policy in public housing 2017. Available at: https://www.hud.gov/sites/documents/SMOKEFREE_GUIDEBK.PDF.

    Google Scholar 

  16. Vijayaraghavan M, Benmarnhia T, Pierce JP, White MM, Kempster J, Shi Y, et al. Income disparities in smoking cessation and the diffusion of smoke-free homes among U.S. smokers: Results from two longitudinal surveys. PLoS One. 2018;13(7):e0201467.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vijayaraghavan M, Messer K, White MM, Pierce JP. The effectiveness of cigarette price and smoke-free homes on low-income smokers in the United States. Am J Public Health. 2013;103(12):2276–83.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Gilpin EA, Messer K, Pierce JP. Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success? Nicotine Tob Res. 2006;8(5):661–9.

    Article  PubMed  Google Scholar 

  19. Durazo A, Hartman-Filson M, Perez K, Alizaga NM, Petersen AB, Vijayaraghavan M. Smoke-free home intervention in permanent supportive housing: a multifaceted intervention pilot. Nicotine Tob Res. 2021;23(1):63–70.

    Article  PubMed  Google Scholar 

  20. Vijayaraghavan M, King BA. Advancing housing and health: promoting smoking cessation in permanent supportive housing. Public Health Rep. 2020;135(4):415–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health. 2004;94(3):416–22.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hayes RJ, Moulton L. Cluster Randomized Trials. 2nd ed. London: Chapman & Hall/CRC Biostatistics Series; 2009.

  23. Bandura A. Social foundations of thought and action: a social cognitive theory: prentice-hall. 1986.

  24. Michie S, Van Stralen M, West R. The behavior change wheel: a new method for characterising and designing behavior change interventions. Implement Sci. 2011;6(42):1–11.

    Google Scholar 

  25. Mangurian CNG, Schillinger D, Newcomer JW, Dilley J, Handley MA. Utilization of the behavior change wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness. Implement Sci. 2017;12(1):134.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Handley MA, Harleman E, Gonzalez-Mendez E, Stotland NE, et al. Applying the COM-B model to creation of an IT-enabled health coaching and resource linkage program for low-income Latina moms with recent gestational diabetes: the STAR MAMA program. Implement Sci. 2016;11(1):73.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: a quick reference guide for clinicians. Rockville: US Department of Health and Human Services; 2000.

    Google Scholar 

  28. Verification SSoB. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2001;4:149–59.

    Google Scholar 

  29. Sudore RL, Landefeld CS, Williams BA, Barnes DE, Lindquist K, Schillinger D. Use of a modified informed consent process among vulnerable patients: a descriptive study. J Gen Intern Med. 2006;21(8):867–73.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ahalt C, Sudore R, Bolano M, Metzger L, Darby AM, Williams B. “Teach-to-goal” to better assess informed consent comprehension among incarcerated clinical research participants. AMA J Ethics. 2017;19(9):862–72.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Vijayaraghavan M, Penko J, Vittinghoff E, Bangsberg DR, Miaskowski C, Kushel MB. Smoking behaviors in a community-based cohort of HIV-infected indigent adults. AIDS Behav. 2014;18:535–43.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Vijayaraghavan M, Penko J, Bangsberg DR, Miaskowski C, Kushel MB. Opioid Analgesic Misuse in a Community-Based Cohort of HIV-Infected Indigent Adults. JAMA Intern Med. 2013;173(3):235–7.

    Article  PubMed  Google Scholar 

  33. Vijayaraghavan M, Freitas D, Bangsberg DR, Miaskowski C, Kushel MB. Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug Alcohol Depend. 2014;143:263–7.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.

    Article  PubMed  Google Scholar 

  36. Larson CO. Use of the SF-12 instrument for measuring the health of homeless persons. Health Serv Res. 2002;37(3):733–50.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.

    Article  CAS  PubMed  Google Scholar 

  38. Centers for Disease Control and Prevention. National Health Interview Survey. 2017.

    Google Scholar 

  39. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D. Am J Prev Med. 1994;10(2):77–84.

    Article  CAS  PubMed  Google Scholar 

  40. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    Article  PubMed  Google Scholar 

  41. Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins-Guarnieri MA, et al. The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31(10):1206–11.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jaffee KD, Liu GC, Canty-Mitchell J, Qi RA, Austin J, Swigonski N. Race, urban community stressors, and behavioral and emotional problems of children with special health care needs. Psychiatr Serv. 2005;56(1):63–9.

    Article  PubMed  Google Scholar 

  43. World Health Organization ASSIST Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.

    Article  Google Scholar 

  44. Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.

    Article  PubMed  Google Scholar 

  45. Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26.

    Article  PubMed  Google Scholar 

  46. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, Project ACQI. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789–95.

    Article  CAS  PubMed  Google Scholar 

  47. Aalto M, Alho H, Halme JT, Seppa K. The alcohol use disorders identification test (AUDIT) and its derivatives in screening for heavy drinking among the elderly. Int J Geriatr Psychiatry. 2011;26(9):881–5.

    Article  PubMed  Google Scholar 

  48. Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, et al. An improved brief measure of cannabis misuse: the Cannabis use disorders identification test-revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1–2):137–43.

    Article  PubMed  Google Scholar 

  49. Williams DR, Yu Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2(3):335–51.

    Article  CAS  PubMed  Google Scholar 

  50. Delucchi KL, Tajima B, Guydish J. Development of the smoking knowledge, attitudes, and practices (S-KAP) instrument. J Drug Issues. 2009;39(2):347–64.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Vijayaraghavan M, Guydish J, Pierce JP. Building tobacco cessation capacity in homeless shelters: a pilot study. J Community Health. 2016;41(5):998–1005.

    Article  PubMed  Google Scholar 

  52. Kegler MC, Bundy L, Haardorfer R, Escoffery C, Berg C, Yembra D, et al. A minimal intervention to promote smoke-free homes among 2-1-1 callers: a randomized controlled trial. Am J Public Health. 2015;105(3):530–7.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Hammond SK, Roche AC, Schenker M. Marker for environmental tobacco smoke. Atmospher Environ. 1986;21(2):457–72.

    Article  Google Scholar 

  54. Rubin DB. Inference and missing data. Biometrika. 1976;63:581–92.

    Article  Google Scholar 

  55. Little RJ, Rubin D. Statistical analysis with missing data. 2nd ed. New York: Wiley; 2002.

    Book  Google Scholar 

  56. Schafer J. Analysis of incomplete multivariate data. London: Chapman & Hall; 1997.

    Book  Google Scholar 

  57. D’Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.

    Article  PubMed  Google Scholar 

  58. Rosenbaum PR. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;60:41–55.

    Article  Google Scholar 

  59. Rosenbaum PR, Rubin DB. Reducing bias in observations studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–24.

    Article  Google Scholar 

  60. Thorpe LE, Feinberg AM, Elbel B, Gordon T, Kaplan SA, Wyka K, et al. Time to track health outcomes of smoke-free multiunit housing. Am J Prev Med. 2018;54(2):320–2.

    Article  PubMed  Google Scholar 

  61. Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 surgeon General's report: “the health consequences of smoking–50 years of Progress”: a paradigm shift in cancer care. Cancer. 2014;120(13):1914–6.

    Article  PubMed  Google Scholar 

  62. Winickoff JP, Gottlieb M, Mello MM. Regulation of smoking in public housing. N Engl J Med. 2010;362(24):2319–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. King BA, Babb SD, Tynan MA, Gerzoff RB. National and state estimates of secondhand smoke infiltration among US multiunit housing residents. Nicotine Tob Res. 2013;15(7):1316–21.

    Article  CAS  PubMed  Google Scholar 

  64. Miller J, Vijayaraghavan M. Tobacco industry efforts to respond to smoke-free policies in multi-unit housing: an evaluation of tobacco industry documents. Int J Environ Res Public Health. 2022;19(5):3053.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Thorpe LE, Anastasiou E, Wyka K, Tovar A, Gill E, Rule A, et al. Evaluation of Secondhand Smoke Exposure in New York City Public Housing After Implementation of the 2018 Federal Smoke-Free Housing Policy. JAMA Netw Open. 2020;3(11):e2024385.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Jiang N, Gill E, Thorpe LE, Rogers ES, de Leon C, Anastasiou E, et al. Implementing the Federal Smoke-Free Public Housing Policy in New York City: Understanding Challenges and Opportunities for Improving Policy Impact. Int J Environ Res Public Health. 2021;18(23):12565.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Hernandez D. Supporting Smoke-Free Policy Compliance in Public Housing. ClinicalTrials.gov Identifier: NCT05016505; 2022.

    Google Scholar 

  68. Leifheit KM, Schwartz GL, Pollack CE, Linton SL. Building health equity through housing policies: critical reflections and future directions for research. J Epidemiol Community Health. 2022;76(8):759–63.

    Article  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the residents and staff of the PSH sites included in this protocol.

Funding

This project is funded by the U.S. National Institutes of Health, National Cancer Institute (Grant 1R01CA248448-01A1). The funders were not involved in the design of the study, data collection, analysis or interpretation findings, or manuscript writing.

Author information

Authors and Affiliations

  1. National Clinician Scholars Program, University of California San Francisco, San Francisco, CA, USA

    Rachel Odes

  2. Division of General Internal Medicine, University of California San Francisco, CA, San Francisco, USA

    Jessica Alway & Maya Vijayaraghavan

  3. Division of Vulnerable Populations, University of California San Francisco, San Francisco, CA, USA

    Margot Kushel

  4. Institute for Health & Aging, School of Nursing, University of California San Francisco, San Francisco, CA, USA

    Wendy Max

Authors
  1. Rachel Odes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica Alway
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margot Kushel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wendy Max
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maya Vijayaraghavan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MV, WM, and MK were responsible for conceptualizing this study, conducting the investigation, and developing the methodology. MV was responsible for funding acquisition, project administration, assembling and deploying resources to conduct the study, supervising the performance of study activities, and validating the work performed by the study team, and creating the initial visualizations to reflect study activities. RO wrote the original draft of this manuscript, and RO, JA, WM, MK, and MV substantively edited and reviewed the final manuscript. The authors read and approved the final manuscript.

Authors’ information

RO is a psychiatric nurse and postdoctoral fellow in the National Clinician Scholars Program at the University of California, San Francisco.

JA is a clinical research coordinator for the Smoke-Free Home intervention study at the University of California, San Francisco.

WM is Professor Emerita of Health Economics at the University of California, San Francisco.

MK is a Professor of Medicine and Division Chief at the Division of Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center and Director of the University of California, San Francisco Center for Vulnerable Populations and University of California, San Francisco Benioff Homelessness and Housing Initiative.

MV is Associate Professor of Medicine, and Co-director of the Benioff Homelessness and Housing Initiative and Center for Tobacco Control Research and Education post-doctoral scholar program at the University of California, San Francisco.

Corresponding author

Correspondence to Maya Vijayaraghavan.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the University of California San Francisco Institutional Review Board (IRB number: 20–33214). The study was considered minimal risk, and does not require a data and safety monitoring board. Participation in this study is voluntary and all participants are provided with information about the study and have an opportunity to ask questions about the study prior to enrollment. Participants sign a consent document and are provided information about potential risks and benefits to participation and the anticipated time commitment. Participants are allowed to withdraw from the study at any time and for any reason. Protocol modifications will be submitted to the IRB for approval. The protocol is in its third version and was approved on July 5, 2022.

Consent for publication

This protocol paper does not contain any information about specific individuals. The study described in the paper will collect information about individuals, but any resulting published work will not identify them.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Odes, R., Alway, J., Kushel, M. et al. The smoke-free home study: study protocol for a cluster randomized controlled trial of a smoke-free home intervention in permanent supportive housing. BMC Public Health 22, 2076 (2022). https://doi.org/10.1186/s12889-022-14423-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-14423-y

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us